10-Q: Select Medical Holdings Reports Strong Q1 2024 Results Driven by Hospital Segment Growth

Select Medical Holdings Corporation reported a significant increase in revenue and profitability for the first quarter of 2024, primarily driven by strong performance in its critical illness recovery and rehabilitation hospital segments.

Summary

• Select Medical Holdings Corporation's revenue for the first quarter of 2024 reached $1.788 billion, a 7.4% increase compared to $1.665 billion in the same period of 2023.
• The company's net income for Q1 2024 was $117.2 million, up from $85.3 million in Q1 2023.
• Adjusted EBITDA for the quarter was $261.9 million, a 22.4% increase year-over-year, with an adjusted EBITDA margin of 14.6%.
• The critical illness recovery hospital segment saw a 10.4% revenue increase, reaching $655.9 million, and a 51% increase in Adjusted EBITDA to $115.9 million.
• The rehabilitation hospital segment experienced a 14.8% revenue increase to $265.7 million and a 30% increase in Adjusted EBITDA to $61.4 million.
• The outpatient rehabilitation segment's revenue increased by 2.5% to $303.2 million, but Adjusted EBITDA decreased by 17.5% to $24.9 million.
• The Concentra segment's revenue increased by 2.5% to $467.6 million, with a 2.6% increase in Adjusted EBITDA to $96.1 million.
• The company's operating expenses were $1.543 billion, or 86.3% of revenue, compared to $1.461 billion, or 87.7% of revenue, in the same period last year.
• The company's days sales outstanding increased to 58 days at March 31, 2024, compared to 52 days at December 31, 2023, primarily due to the Change Healthcare cybersecurity incident.

Sentiment

Score: 8

Explanation: The document presents a positive outlook with strong financial results, particularly in the hospital segments. The planned separation of Concentra is a significant strategic move. However, the cybersecurity incident and increased days sales outstanding are areas of concern, preventing a higher score.

Positives

• The company experienced significant revenue growth in its critical illness recovery and rehabilitation hospital segments.
• The company's net income and Adjusted EBITDA showed substantial year-over-year increases.
• The company's contract labor costs decreased by approximately 20% year-over-year.
• The company maintains strong liquidity and has access to a revolving credit facility.
• The company is progressing with the planned separation of Concentra into a new, publicly traded company.

Negatives

• The outpatient rehabilitation segment experienced a decrease in Adjusted EBITDA and margin.
• The company's cash flows from operations were negatively impacted by the Change Healthcare cybersecurity incident.
• The company's days sales outstanding increased to 58 days at March 31, 2024, compared to 52 days at December 31, 2023.
• The company's outpatient rehabilitation segment saw a decrease in revenue per visit due to a decrease in Medicare reimbursement and changes in payor mix.

Risks

• Changes in government reimbursement policies could negatively impact revenue and profitability.
• Adverse economic conditions, including inflation, could increase labor and other operating costs.
• Shortages of qualified healthcare professionals could limit the company's ability to staff facilities.
• Public health threats, such as pandemics, could negatively impact patient volumes and revenues.
• Government investigations or assertions of regulatory violations could result in sanctions and increased costs.
• The company faces risks related to the potential separation of Concentra, including the possibility that the separation may not be completed or achieve the expected benefits.
• The company is subject to cybersecurity risks, as evidenced by the Change Healthcare incident and the Perry Johnson & Associates data breach.

Future Outlook

The company intends to separate Concentra into a new, publicly traded company by the end of fiscal year 2024. The company believes its internally generated cash flows and borrowing capacity will allow it to finance operations in both the short and long term. The company may pursue opportunities to develop new joint venture relationships and open new outpatient rehabilitation clinics and occupational health centers. The company may also grow through opportunistic acquisitions.

Management Comments

• Management uses Adjusted EBITDA to evaluate financial performance and determine resource allocation for each of its segments.
• Management believes that the presentation of Adjusted EBITDA is important to investors because it is commonly used as an analytical indicator of performance by investors within the healthcare industry.

Industry Context

The healthcare industry is experiencing a period of change, with regulatory updates, cybersecurity threats, and evolving reimbursement models. Select Medical's performance reflects the challenges and opportunities within this environment, particularly in the areas of hospital operations and outpatient services. The company's focus on managing labor costs and expanding its service offerings aligns with broader industry trends.

Comparison to Industry Standards

• Select Medical's revenue growth of 7.4% year-over-year is a strong result compared to some of its peers in the healthcare services sector, although specific comparisons are difficult without detailed data from competitors.
• The company's Adjusted EBITDA margin of 14.6% is a solid performance, but it is important to compare this to other companies in the same sub-sectors, such as long-term care hospitals, rehabilitation facilities, and outpatient clinics.
• For example, companies like Encompass Health (EHC) in the rehabilitation space and HCA Healthcare (HCA) in the hospital sector would be relevant comparators, but their specific Q1 2024 results would need to be analyzed for a detailed comparison.
• The increase in days sales outstanding to 58 days is a concern and should be monitored against industry benchmarks, as it indicates a potential slowdown in cash collection.
• The company's focus on reducing contract labor costs is a positive trend, as many healthcare providers are facing similar challenges with rising labor expenses.

Legal Proceedings

• The company is involved in various legal actions, proceedings, and claims, including regulatory and governmental audits and investigations.
• The company is cooperating with investigations by the U.S. Attorneys Office for the Western District of Oklahoma, the U.S. Department of Justice, and the California Department of Insurance.
• The company is facing multiple class action lawsuits related to the Perry Johnson & Associates, Inc. data breach.

Stakeholder Impact

• Shareholders will benefit from the company's strong financial performance and the potential value creation from the Concentra separation.
• Employees may be impacted by changes in labor costs and the company's efforts to manage staffing levels.
• Patients will continue to receive care at the company's various facilities.
• Customers, including employers and insurance companies, will be affected by the company's service offerings and pricing.
• Suppliers will be impacted by the company's purchasing decisions and payment practices.
• Creditors will be affected by the company's debt levels and ability to meet its financial obligations.

Next Steps

• The company will continue to monitor the impact of the Change Healthcare cybersecurity incident on its billing and collections processes.
• The company will proceed with the planned separation of Concentra into a new, publicly traded company.
• The company will continue to evaluate opportunities for growth through joint ventures, new facility openings, and acquisitions.
• The company will continue to manage its labor costs and other operating expenses.
• The company will continue to monitor and respond to regulatory changes in the healthcare industry.

Key Dates

Keywords

healthcare, hospitals, rehabilitation, outpatient, critical illness recovery, occupational health, Concentra, EBITDA, revenue, Medicare, cybersecurity, financial results